Latest Administration News

Arena REIT has announced its December 2025 quarter distribution of 4.8125 cents per stapled security, reflecting steady income from its social infrastructure portfolio. The distribution includes components relevant for tax purposes, underscoring the REIT’s ongoing compliance and investor transparency.

Hydrix Limited has amended its quarterly cash flow report, revealing stronger customer receipts and a stable cash position supported by robust financing facilities.

Neurotech International has secured ethics approval to launch its Beyond Harmony Phase 3 clinical trial of NTI164 for autism spectrum disorder, marking a key step toward regulatory submissions in Australia and the US.

The ASX has suspended trading in Aspermont Limited, Koba Resources, and WA Kaolin due to their failure to lodge required periodic reports on time. The suspension may be lifted if the companies submit their reports promptly.

Imagion Biosystems has submitted its Investigational New Drug application to the U.S. FDA for its MagSense® HER2 Imaging Agent, marking a pivotal step toward launching a Phase 2 clinical trial for breast cancer detection.

Tempest Minerals and Capricorn Metals have agreed to extend the completion date for the Yalgoo Project sale to mid-February 2026, allowing time to finalise administrative and regulatory requirements without altering deal terms.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.

Lithium Energy Limited has completed the sale of its Solaroz Lithium Brine Project, receiving US$21.7 million in cash and setting the stage for renewed focus on its graphite and gold-copper assets. The company is actively progressing exploration and development programs to meet ASX reinstatement criteria.

Bowen Coking Coal Limited has reported a challenging quarter ending December 2025, marked by cash outflows, a default on its senior secured debt, and ongoing voluntary administration.

Bowen Coking Coal maintained steady production in the December quarter despite ongoing administration and a challenging market, though rising costs and a 12% sales dip highlight operational pressures.

ChemX Materials Limited remains suspended from ASX trading as it finalises overdue financial reports and secures informal funding, aiming for share reinstatement.

Evion Group has bolstered its cash reserves to $2.3 million following a strategic placement and secured a $1.5 million expandable graphite sales agreement in the US, while advancing its Maniry Graphite Project in Madagascar with strong EU backing.